Myriad Genetics, Inc. (MYGN) financial statements (2022 and earlier)

Company profile

Business Address 320 WAKARA WAY
SALT LAKE CITY, UT 84108
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:399218137181151159145
Cash and cash equivalents258164931111026964
Short-term investments81544470489181
Other undisclosed cash, cash equivalents, and short-term investments59      
Receivables91711391021119588
Inventory, net of allowances, customer advances and progress billings15293134423825
Inventory15293134423825
Prepaid expense18 25 04 
Deferred tax assets    14
Other undisclosed current assets(39)14179131813
Total current assets:485332349326317315284
Noncurrent Assets
Operating lease, right-of-use asset8266
Property, plant and equipment44375743515867
Long-term investments and receivables59375531498041
Long-term investments59375531498041
Intangible assets, net (including goodwill)6439331,102774808423370
Goodwill239328417319316195177
Intangible assets, net (excluding goodwill)404605685455492228193
Other noncurrent assets8    55
Deferred tax assets, net    (0)
Other undisclosed noncurrent assets      0
Total noncurrent assets:8361,0731,214848907566483
TOTAL ASSETS:1,3211,4051,5631,1741,224881766
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18698112948871105
Accounts payable30223326222121
Accrued liabilities157767968665046
Employee-related liabilities      34
Taxes payable      4
Deferred revenue533
Business combination, contingent consideration, liability 335127  
Deferred revenue and credits 322
Contract with customer, liability2
Other undisclosed current liabilities1314 3  (38)
Total current liabilities:2041471181022187269
Noncurrent Liabilities
Long-term debt and lease obligation792812349   
Long-term debt, excluding current maturities 2242349   
Operating lease, liability7957
Liabilities, other than long-term debt, including:41358671814
Deferred tax liabilities, net835784 0
Deferred income tax liabilities3627
Liability, pension and other postretirement and postemployment benefits     65
Other liabilities64867129
Business combination, contingent consideration, liability 410913  
Other undisclosed liabilities, other than long-term debt  (93)(67)(98)  
Other undisclosed noncurrent liabilities2824115912224222
Total noncurrent liabilities:1493393561072296035
Total liabilities:353486474209447132104
Stockholders' equity
Stockholders' equity attributable to parent9689181,089965778748662
Common stock1111111
Additional paid in capital1,2261,0971,068915851830745
Accumulated other comprehensive loss(5)(5)(5)(4)(6)(10)(7)
Retained earnings (accumulated deficit)(254)(174)2653(68)(73)(77)
Stockholders' equity attributable to noncontrolling interest    (0)  
Total stockholders' equity:9689181,089965778748662
TOTAL LIABILITIES AND EQUITY:1,3211,4051,5631,1741,224881766

Income statement (P&L) ($ in millions)

12/31/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Revenues691639851773771754723
Revenue, net 771754723
Cost of revenue(297)(111)(130)(30)(145)(133)(133)
Gross profit:394527721743626621590
Operating expenses(584)(759)(714)(624)(551)(430)(499)
Other undisclosed operating income (loss)    (26)(25)42
Operating income (loss):(191)(232)811949167134
Nonoperating income (expense)1338(8)(2)(7)21
Investment income, nonoperating1332110
Other nonoperating income (expense)139161(0)(3)10
Interest and debt expense(7)(11)(12)(3)(1)  
Income (loss) from continuing operations before equity method investments, income taxes:(64)(234)(12)11442169135
Other undisclosed income from continuing operations before income taxes711 31  
Income (loss) from continuing operations before income taxes:(57)(223)(12)11743169135
Income tax expense (benefit)3024414(21)(44)(55)
Income (loss) before gain (loss) on sale of properties:(27)(200)(8)1312212580
Other undisclosed net income  12    
Net income (loss):(27)(200)41312212580
Net income attributable to noncontrolling interest 0000  
Net income (loss) available to common stockholders, diluted:(27)(200)51312212580

Comprehensive Income ($ in millions)

12/31/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Net income (loss):(27)(200)41312212580
Other comprehensive income (loss)    4(3)(6)
Comprehensive income (loss):(27)(200)41312612375
Comprehensive income, net of tax, attributable to noncontrolling interest 0000  
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)0(1)2   
Comprehensive income (loss), net of tax, attributable to parent:(30)(199)31332612375

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: